Beyond biomarkers: the role of clinical factors associated with biologic therapy response in severe asthma
Beyond traditional biomarkers, clinical factors particulary nasal polyposis and AERD may play a key role in understanding response patterns to biologics. Incorporating these variables into clinical assessment may help support a more personalized management approach in severe asthma.
Authors
- J. A. Cañas (ORCID: https://orcid.org/0000-0002-0460-2813)
- Manuel Jorge Rial
- Ignacio Mahíllo-Fernández
- Raquel Lopez-Rodríguez
Institutions
- Instituto de Salud Carlos III (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Complexo Hospitalario Universitario A Coruña (ES)
- Hospital Universitario Lucus Augusti (ES)
- Universidad Carlos III de Madrid (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1080/07853890.2026.2627026
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00